Navigation Links
Knee Osteoarthritis: Autologous Conditioned Serum (ACS) Combined With Physiotherapy Led to Significant Improvement in Pain and Function
Date:2/25/2016

MADRID and DÜSSELDORF, Germany, February 25, 2016 /PRNewswire/ --

Osteoarthritis (OA) of the knee affects 10-15 percent of adults aged over 60 years worldwide (WHO, 2013). There are surgical and non-surgical treatment options. Medicines like hyaluronic acid, corticosteroids, platelet-rich plasma or autologous conditioned serum (ACS/ Orthokine®) can be injected directly into the joint.

The Spanish team of Dr. Jaime Baselga García-Escudero and Dr. Pedro Miguel Hernández Trillos set up a prospective observational study on unilateral knee osteoarthritis which has been published recently in the journal "PLoS ONE", entitled: "Treatment of Osteoarthritis of the Knee with a Combination of Autologous Conditioned Serum and Physiotherapy: A Two-Year Observational Study".  

In this trial 118 patients from 34-81 years participated over 24 months. The average pain at the beginning of the trial was 8.1 on the Numeric Rating Scale (NRS 0-10) which correlated with increased Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores. Patients received four intra-articular injections of 2 mL of ACS once weekly over four weeks. The injection therapy was followed by 30 sessions of physiotherapy.

Results 

In this study NRS pain scores declined significantly by over 60% during the first three months after treatment and remained steady. The WOMAC global, pain and function score decreased significantly, too. The results from this study were independent from age, gender, weight and stage of disease. "The improvement in pain and function reported in this observational study is impressive", said Prof. Dr. Peter Wehling, CEO of Orthogen AG, Düsseldorf, Germany.

About ACS/ Orthokine® 

Orthokine®, branded in Germany Orthokin®, is an autologous blood product derived from the patient's own blood. To produce the product, EOTII syringes (Orthogen Lab Services GmbH, Düsseldorf, Germany) are used.

http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0145551 (22.2.2016)

Full release at: http://www.presseportal.de/nr/59057

Contact:
Peter Wehling
Phone: +49(0)211-3870012
E-Mail press@orthogen.com



'/>"/>
SOURCE Orthogen AG
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1 Selected for Oral Presentation at the 2015 ASCO Annual Meeting
2. Essential Pharmaceuticals LLC releases Cell-Ess serum replacement for use in cell culture instead of FBS
3. PBL Assay Science announces ultra-sensitive assay services to measure biomolecules in human serum or plasma
4. CA BOTANA Introduces SEA ENZYME CALIFORNIA BOTANICAL HAIR SERUM
5. Jeeven BioSciences, Inc. Announces the Release of its Neuro-X(TM) Serum Free and Xeno Free Tissue Culture Media
6. Global Acute Coronary Syndrome (ACS) Market 2015-2019
7. Polaris Groups ADI-PEG 20 Shows Robust Clinical Activity in Malignant Plural Mesothelioma and NSCLC When Combined with Standard First Line Chemotherapy Regimen
8. Atopic Dermatitis Market Sales to Hit $5.6 Billion by 2022 Combined for Nine Major Countries
9. Sorin And Cyberonics Announce Designees To Board Of Directors Of Combined Company
10. Quest Diagnostics Announces Early Tender Date Results of Cash Tender Offers for Up to $250 Million Combined Aggregate Principal Amount of Certain of its Outstanding Notes
11. Quest Diagnostics Announces Pricing of Cash Tender Offers for Up to $250 Million Combined Aggregate Principal Amount of Certain of its Outstanding Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, https://wcg.swoogo.com/modern-sop-and-quality-systems , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):